4.3 Review

Mirabegron: a safety review

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Emerging drugs for treatment of urinary incontinence

Monika Vij et al.

EXPERT OPINION ON EMERGING DRUGS (2010)

Article Medicine, General & Internal

Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage

Miriam G. Cisternas et al.

CURRENT MEDICAL RESEARCH AND OPINION (2009)

Review Pharmacology & Pharmacy

β3-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF OVERACTIVE BLADDER

P. Tyagi et al.

DRUGS OF THE FUTURE (2009)

Meeting Abstract Pharmacology & Pharmacy

IMMUNE-MODULATION BY POLYUNSATURATED FATTY ACIDS

A. Hogenkamp et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)

Article Medicine, General & Internal

Using anticholinergics to treat overactive bladder: The issue of treatment tolerability

DR Staskin et al.

AMERICAN JOURNAL OF MEDICINE (2006)

Article Pharmacology & Pharmacy

Integrative control of the lower urinary tract: preclinical perspective

WC de Groat

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Urology & Nephrology

Definition and epidemiology of overactive bladder

AJ Wein et al.

UROLOGY (2002)